Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS –(BUSINESS WIRE)– Medable Inc. , In 2024, expect to see more innovative technologies and new ways of delivering streamlined, patient-centric trials from Medable.”

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Healthcare IT Today

JANUARY 8, 2024

For the pharmacovigilance space, for example, this automation will begin as a tool for recommendations, suggestions or options for potential safety reports, but it will not fully replace human efforts particularly as there are concerns around data output consistency.

Health IT 85

Health IT Drug Development Pharmaceuticals BioTech 85

Digital Health Global

SEPTEMBER 28, 2023

These are inspiring times for novel ideas to come to life , as new disruptive AI models reveal fresh insights from complex data and dramatically accelerate the application of research learning into future standards of care. The fund has already started its activity with two Seed investments, with two more to be announced soon.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Healthcare IT News - Telehealth

JANUARY 20, 2022

That is the opinion of Ron Emerson, RN, global healthcare lead at Zoom, as he looks ahead at what he believes will be some developments in healthcare in 2022. One example of how video-assisted virtual visits provide easy access for patients is the ability to capture objective data over video without the need for medical devices.

Life Science 185

Life Science Primary Care Mental health Drug Development 185

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.

Life Science 88

Life Science BioTech Drug Development Health science 88

Digital Health Global

NOVEMBER 20, 2023

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. They can view historic data and forecast future trends.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Lloyd Price

FEBRUARY 18, 2024

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Gain access to new technologies and data assets. Leverage data and analytics capabilities.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Leadership 64

Lloyd Price

DECEMBER 11, 2023

Health Tech founder and M&A Advisor Lloyd Price believes virtual care can bring a sweep of benefits, but cautions that it will still need to find a way through barriers around access and affordability for patients, the security of patient data and the licensing of healthcare providers to practice across geographical and care boundaries.

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Healthcare IT Today

JANUARY 23, 2024

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Drug Development 94

Drug Development Pharmaceuticals Life Science BioTech 94

Lloyd Price

DECEMBER 8, 2018

Life-sciences companies recorded the strongest gains, Fenwick found, with their valuations rising 110% compared with their prior funding rounds. But key facets of its business didn’t develop as planned, say people familiar with the company.

Pharmaceuticals 56

Pharmaceuticals Life Science BioTech Drug Development 56

Healthcare IT Today

APRIL 25, 2024

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.

Pharmaceuticals 120

Pharmaceuticals Drug Development BioTech Life Science 120

Digital Health Global

MARCH 29, 2023

Genialis is developing next-generation patient classifiers using machine learning and high-throughput omics data to capture underlying disease biology and predict how patients will likely respond to targeted therapies. ResponderID yields new biomarkers for drug development and discovery programs, as well as diagnostic tests.

Drug Development 167

Drug Development Pharmaceuticals Life Science Digital Health 167

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. The use of DHTs in neurology trials produced consistent benefits on many levels.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Dr. Bernd Seizinger, M.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. According to a recent Deloitte article , ROI on pharma R&D has steadily declined, reaching 1.2

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Henry Kotula

MARCH 10, 2021

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

The Digital Health Corner

MARCH 26, 2018

1] [6] Each block typically contains a cryptographic hash of the previous block, [6] a timestamp and transaction data. [7] 7] By design, a blockchain is inherently resistant to modification of the data. Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health.

Digital Health 117

Digital Health Interoperability Life Science Healthcare Data Security 117

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. It’s also not a secret that 3rd party data has huge implications as key social determinants of health (availability of healthy food at the grocery store, distance to a pharmacy etc.). Check out our community’s pharma predictions.

Health IT 92

Health IT Pharmaceuticals Drug Development Life Science 92

Healthcare IT Today

JANUARY 17, 2024

As behavioral health practitioners, we must make our voices heard from the very beginning of the generative AI conversation to bring the evidence-based data and experience to the conversation. Embrace the value while protecting the data. It is all too easy for non-clinicians to bear on what is a therapeutic clinical experience.

Health IT 110

Health IT Mental health Interoperability Patient Experience 110